Celldex Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Celldex Therapeutics M&A Summary

Celldex Therapeutics has acquired 3 companies.

Celldex Therapeutics’ largest acquisition to date was in 2009, when it acquired CuraGen for $95M. Celldex Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Celldex Therapeutics Business Overview

Where is Celldex Therapeutics headquartered?

Celldex Therapeutics is headquartered in Hampton, New Jersey.

What is Celldex Therapeutics’ revenue?

Celldex Therapeutics disclosed revenue of 5M USD for 2021 and 7M USD for 2020.

How many employees does Celldex Therapeutics have?

Celldex Therapeutics has 148 employees.

What sector is Celldex Therapeutics in?

Celldex Therapeutics is a life science company.

When was Celldex Therapeutics founded?

Celldex Therapeutics was founded in 1983.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 3

Celldex Therapeutics

Celldex Therapeutics, Inc.

Perryville III Building, Suite 220 53 Frontage Road,
Hampton, New Jersey 08827
United States,
(908) 200-7500
www.celldex.com

Celldex Therapeutics is an integrated bio pharmaceutical company that applies its comprehensive precision targeted immunotherapy platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex’s immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. Celldex Therapeutics was founded in 1983 and is based in Hampton, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $157M $157M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Kolltan Pharmaceuticals, Inc. 2016-11-01 63M USD Add-on Acquisition
New Haven, Connecticut · www.kolltan.com
CuraGen Corporation 2009-03-29 95M USD Add-on Acquisition
Branford, Connecticut
Alteris Therapeutics Inc. 2005-10-12 - Add-on Acquisition
Philadelphia, Pennsylvania · www.alteristhera.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 157M (100%) - -
Total 3 $157M - -

By Geo

State/Country Buy Value Sell Value
United States 3 157M - -
  Connecticut 2 157M - -
  Pennsylvania 1 - - -
Total 3 $157M - -

Top M&A Advisors

Financial Deals
WBB Securities, LLC
1
Brean Capital LLC
1
Legal Deals
Lowenstein Sandler
2

Deal Values

buy # Total
< $100M 2 $157M
TOTAL $157M
Largest CuraGen Corporation
$95M (2009-03-29)

 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.